JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

JNJ

229.87

+1.14%↑

UNH

370.84

+0.14%↑

TMO

478.44

+2.91%↑

ISRG

457.44

+1.12%↑

ABT

90.76

-0.82%↓

Search

VistaGen Therapeutics Inc

Închisă

0.61 3.39

Rezumat

Modificarea prețului

24h

Curent

Minim

0.58

Maxim

0.61

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+66.67% upside

Dividende

By Dow Jones

Următoarele câștiguri

16 iun. 2026

VistaGen Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

30 apr. 2026, 23:08 UTC

Câștiguri

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 23:07 UTC

Câștiguri

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 22:20 UTC

Câștiguri

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

30 apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

30 apr. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

30 apr. 2026, 23:47 UTC

Market Talk

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

30 apr. 2026, 23:27 UTC

Market Talk

Liontown Lithium Recovery Expected to Improve -- Market Talk

30 apr. 2026, 23:22 UTC

Câștiguri

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

30 apr. 2026, 23:20 UTC

Market Talk

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

30 apr. 2026, 22:52 UTC

Câștiguri

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30 apr. 2026, 22:33 UTC

Câștiguri

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

30 apr. 2026, 22:32 UTC

Câștiguri

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

30 apr. 2026, 22:32 UTC

Câștiguri

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

30 apr. 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

30 apr. 2026, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

30 apr. 2026, 22:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 apr. 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

30 apr. 2026, 22:11 UTC

Market Talk

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

30 apr. 2026, 22:05 UTC

Câștiguri

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

30 apr. 2026, 21:57 UTC

Câștiguri

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

30 apr. 2026, 21:56 UTC

Câștiguri

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

30 apr. 2026, 21:56 UTC

Câștiguri

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

30 apr. 2026, 21:55 UTC

Câștiguri

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

30 apr. 2026, 21:54 UTC

Câștiguri

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

30 apr. 2026, 21:54 UTC

Câștiguri

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

30 apr. 2026, 21:53 UTC

Câștiguri

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

30 apr. 2026, 21:49 UTC

Câștiguri

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

30 apr. 2026, 21:49 UTC

Câștiguri

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

Comparație

Modificare preț

VistaGen Therapeutics Inc Așteptări

Obiectiv de preț

By TipRanks

66.67% sus

Prognoză pe 12 luni

Medie 1 USD  66.67%

Maxim 1 USD

Minim 1 USD

În baza a 2 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruVistaGen Therapeutics Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

2 ratings

0

Cumpărare

2

Păstrare

0

Vânzare

Date financiare

$

help-icon Live chat